Jenburkt Pharma Financials
BSE: 524731
₹1,039.90
₹-3.10
(-0.30%)
As on 08-Sep-2026 14:37IST
Market cap
₹459 Cr
Revenue (TTM)
₹169 Cr
P/E Ratio
14
P/B Ratio
2.3
Div. Yield
2 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
168.73
|
168.74
|
151.69
|
141.97
|
136.75
|
123.98
|
|
|
|
|
|
|
Total Income
|
178.48
|
179.04
|
158.41
|
146.63
|
141.87
|
128.93
|
|
|
|
|
|
|
Total Expenditure
|
127.92
|
125.00
|
111.30
|
108.85
|
106.38
|
96.73
|
|
|
|
|
|
|
EBITDA
|
40.81
|
43.74
|
40.39
|
33.12
|
30.37
|
27.26
|
|
|
|
|
|
|
Depreciation
|
3.03
|
3.11
|
2.73
|
2.34
|
2.26
|
1.90
|
|
|
|
|
|
|
EBIT
|
37.78
|
40.63
|
37.66
|
30.78
|
28.11
|
25.36
|
|
|
|
|
|
|
Interest
|
0.48
|
0.46
|
0.45
|
0.27
|
0.37
|
0.43
|
|
|
|
|
|
|
Other Income
|
9.76
|
10.30
|
6.72
|
4.67
|
5.12
|
4.95
|
|
|
|
|
|
|
Exceptional Items
|
-3.95
|
-3.95
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
43.11
|
46.52
|
43.93
|
35.18
|
32.86
|
29.87
|
|
|
|
|
|
|
Provision for Tax
|
10.28
|
11.78
|
11.87
|
9.20
|
8.26
|
7.57
|
|
|
|
|
|
|
Profit after Tax
|
32.83
|
34.74
|
32.06
|
25.98
|
24.61
|
22.30
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
197.04
|
197.04
|
171.78
|
144.94
|
122.39
|
117.38
|
|
|
|
|
|
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Non-Current Liabilities
|
5.83
|
3.43
|
4.12
|
2.98
|
3.24
|
3.92
|
|
|
|
|
|
|
Current Liabilities
|
23.15
|
23.15
|
18.82
|
16.38
|
15.76
|
21.28
|
|
|
|
|
|
|
Total Liabilities
|
226.01
|
225.04
|
195.10
|
164.31
|
141.39
|
142.58
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
87.09
|
128.52
|
138.19
|
54.57
|
60.30
|
66.67
|
|
|
|
|
|
|
Current Assets
|
95.09
|
95.09
|
56.53
|
109.73
|
81.09
|
75.90
|
|
|
|
|
|
|
Total Assets
|
226.01
|
225.04
|
195.10
|
164.31
|
141.39
|
142.58
|
|
|
|
|
|
|
Total Debt*
|
--
|
--
|
1.98
|
--
|
2.44
|
5.82
|
|
|
|
|
|
|
Net Current Assets
|
71.94
|
71.94
|
37.71
|
93.35
|
65.33
|
54.62
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
17.20
|
16.50
|
16.57
|
19.55
|
16.61
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
26.52
|
27.91
|
8.12
|
17.05
|
9.27
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-19.45
|
-17.04
|
-0.58
|
2.62
|
-1.20
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-8.86
|
-7.62
|
-7.08
|
-21.04
|
-5.53
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-1.79
|
3.24
|
0.47
|
-1.37
|
2.54
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
81.47
|
78.71
|
72.65
|
58.86
|
55.76
|
48.58
|
|
|
|
|
|
|
Cash EPS (₹)
|
74.39
|
85.75
|
78.83
|
64.16
|
60.88
|
52.72
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
459.80
|
446.47
|
389.23
|
328.42
|
277.32
|
255.77
|
|
|
|
|
|
|
Dividend per Share (₹)
|
1.99
|
20.70
|
18.00
|
15.30
|
14.40
|
12.00
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
60.10
|
63.23
|
18.41
|
38.64
|
20.20
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
47.89
|
35.28
|
17.10
|
42.40
|
22.55
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
25.34
|
27.85
|
26.28
|
26.80
|
26.89
|
|
|
|
|
|
|
ROE (%)
|
18.93
|
18.84
|
20.25
|
19.43
|
20.53
|
20.66
|
|
|
|
|
|
|
ROA (%)
|
15.55
|
16.61
|
17.86
|
17.00
|
17.33
|
16.95
|
|
|
|
|
|
|
EBIT Margin (%)
|
22.39
|
24.08
|
24.83
|
21.68
|
20.55
|
20.45
|
|
|
|
|
|
|
Net Margin (%)
|
18.39
|
19.40
|
20.24
|
17.72
|
17.34
|
17.29
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
0.00
|
22.43
|
22.93
|
19.95
|
19.65
|
19.52
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
9.08
|
11.24
|
6.85
|
3.82
|
10.30
|
13.44
|
|
|
|
|
|
|
EBIT Growth (%)
|
1.76
|
7.88
|
22.37
|
9.50
|
10.85
|
42.40
|
|
|
|
|
|
|
Net Profit Growth (%)
|
10.84
|
8.34
|
23.42
|
5.57
|
10.36
|
35.11
|
|
|
|
|
|
|
EPS Growth (%)
|
1.20
|
8.34
|
23.42
|
5.57
|
14.76
|
35.11
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
14.71
|
18.52
|
18.43
|
4.27
|
19.21
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
13.98
|
12.14
|
13.93
|
11.71
|
11.94
|
11.66
|
|
|
|
|
|
|
Price / Book Value
|
2.26
|
2.14
|
2.60
|
2.10
|
2.40
|
2.22
|
|
|
|
|
|
|
Dividend Yield (%)
|
1.99
|
2.17
|
1.78
|
2.22
|
2.16
|
2.12
|
|
|
|
|
|
|
EV/EBITDA
|
8.03
|
6.82
|
9.00
|
5.96
|
6.83
|
6.73
|
|
|
|
|
|
|
Close Price (₹)
|
1,109.65
|
955.45
|
1,011.70
|
689.45
|
666.00
|
566.65
|
|
|
|
|
|
|
High Price (₹)
|
1,410.00
|
1,410.00
|
1,375.00
|
925.00
|
760.00
|
699.70
|
|
|
|
|
|
|
Low Price (₹)
|
944.00
|
944.00
|
701.20
|
586.90
|
452.10
|
391.10
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
458.98
|
421.67
|
446.49
|
304.28
|
293.93
|
260.06
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
--
|
0.01
|
--
|
0.02
|
0.05
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
--
|
0.01
|
--
|
0.02
|
0.05
|
|
|
|
|
|
|
Current Ratio
|
4.11
|
4.11
|
3.00
|
6.70
|
5.14
|
3.57
|
|
|
|
|
|
|
Quick Ratio
|
3.52
|
3.52
|
2.53
|
6.18
|
4.62
|
3.10
|
|
|
|
|
|
|
Interest Coverage
|
90.43
|
101.69
|
98.02
|
130.99
|
90.55
|
69.76
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
14.44
|
14.43
|
13.67
|
13.72
|
12.40
|
12.27
|
|
|
|
|
|
|
Asset Turnover
|
0.80
|
0.81
|
0.85
|
0.93
|
0.96
|
0.94
|
|
|
|
|
|
|
Receivable days
|
--
|
48.77
|
48.38
|
46.84
|
42.93
|
42.99
|
|
|
|
|
|
|
Inventory Days
|
--
|
24.35
|
20.98
|
21.72
|
24.32
|
25.71
|
|
|
|
|
|
|
Payable days
|
--
|
106.30
|
101.38
|
84.76
|
84.44
|
77.81
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-33.18
|
-32.02
|
-16.20
|
-17.19
|
-9.11
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
